A Study Evaluating the Safety of Stratagraft® Skin Tissue in Promoting Skin Tissue Regeneration of Complex Skin Defects Due to Thermal Burns

Status: open

Phase 3 open-label, controlled, randomized, multicenter study evaluating the efficacy and safety of Stratagraft® skin tissue in promoting autologous skin tissue regeneration of complex skin defects due to thermal burns that contain intact dermal elements

Treatment for Thermal Burns

Contact Us Or call 251-471-7988

Description

The proposed registration study is designed as a phase III open-label, controlled, randomized, multicenter study evaluating the efficacy and safety of StrataGraft skin tissue in promoting autologous skin tissue regeneration of complex skin defects due to thermal burns.

Sponsors

This trial is sponsored by Stratatech.

Providers Associated With This Trial

Principle Investigator

  • Steven KahnView Profile
    Steven Kahn, M.D.Burn/Trauma/Critical Care SurgeonDirector of Arnold Luterman Regional Burn Center; Director of Burn Intensive Care Unit; Assistant Professor of Surgery

Sub Investigators

This link will open in a new tab or window.